Free Trial
NASDAQ:MDRX

Veradigm (MDRX) Stock Price, News & Analysis

Veradigm logo
$9.40
-0.03 (-0.32%)
(As of 10/31/2024 ET)

About Veradigm Stock (NASDAQ:MDRX)

Key Stats

Today's Range
$9.20
$9.43
50-Day Range
$9.00
$9.95
52-Week Range
$5.01
$13.62
Volume
2.39 million shs
Average Volume
1.65 million shs
Market Capitalization
$1.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Hold

Company Overview

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Veradigm Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
50th Percentile Overall Score

MDRX MarketRank™: 

Veradigm scored higher than 50% of companies evaluated by MarketBeat, and ranked 201st out of 338 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Veradigm has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Veradigm has received no research coverage in the past 90 days.

  • Read more about Veradigm's stock forecast and price target.
  • Earnings Growth

    Earnings for Veradigm are expected to grow by 5.04% in the coming year, from $1.39 to $1.46 per share.

  • Short Interest

    There is no current short interest data available for MDRX.
  • Dividend Yield

    Veradigm does not currently pay a dividend.

  • Dividend Growth

    Veradigm does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for MDRX.
  • News Sentiment

    Veradigm has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Veradigm this week, compared to 3 articles on an average week.
  • Search Interest

    3 people have searched for MDRX on MarketBeat in the last 30 days.
  • MarketBeat Follows

    2 people have added Veradigm to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
Receive MDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veradigm and its competitors with MarketBeat's FREE daily newsletter.

MDRX Stock News Headlines

Veradigm (NASDAQ:MDRX) Trading Up 11% - Here's What Happened
This man believes TSLA will reach $500 a share…
Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.
Veradigm Ranked Top Vendor by KLAS
Veradigm (MDRX) Gets a Buy from TD Cowen
See More Headlines

MDRX Stock Analysis - Frequently Asked Questions

Veradigm's stock was trading at $10.49 at the start of the year. Since then, MDRX shares have decreased by 10.4% and is now trading at $9.40.
View the best growth stocks for 2024 here
.

Veradigm Inc. (NASDAQ:MDRX) posted its quarterly earnings data on Thursday, November, 4th. The software maker reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.09. The company's revenue was down 8.2% compared to the same quarter last year.

The following companies are subsidiaries of Veradigm: ZappRx, HealthGrid, and Practice Fusion.

Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Veradigm investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), General Electric (GE) and ServiceNow (NOW).

Company Calendar

Last Earnings
11/04/2021
Today
10/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:MDRX
CUSIP
01988P10
Employees
8,000
Year Founded
1986

Price Target and Rating

Average Stock Price Target
$12.00
High Stock Price Target
$15.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+27.7%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.53 billion
Cash Flow
$2.86 per share

Miscellaneous

Free Float
105,175,000
Market Cap
$1.01 billion
Optionable
No Data
Beta
0.60

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NASDAQ:MDRX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners